Cost-benefit analysis of immune checkpoint inhibitors: Is the price worth their value?

Oral Oncol. 2023 Nov:146:106560. doi: 10.1016/j.oraloncology.2023.106560. Epub 2023 Aug 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents, Immunological*
  • Cost-Benefit Analysis
  • Drug Costs
  • Humans
  • Immune Checkpoint Inhibitors*

Substances

  • Immune Checkpoint Inhibitors
  • Antineoplastic Agents, Immunological